Archive

Novartis India is globally known for its quality medicines. The company has managed to save millions of lives across the globe…

Sponsors Sunjoy Monga’s book 'Mumbai Safari'” as part of its CSR initiative on environment protection

A public listed pharmaceutical company, Abbott India is a part of Abbott’s global pharma business in India. The company believes…

With an aim to provide better healthcare access at affordable cost to all people living in the Indian society, Strand Life…

Sciformix Corporation is a Scientific Process Organization (SPO), providing scientific knowledge-based services to pharmaceutical…

Piramal Foundation runs initiatives that all contribute in nation building. Its focus areas are health, education, youth…

Healthcare experts have constantly raised questions over the standards of child healthcare in India. Being an important…

It is very usual to see companies working in the healthcare industry doing CSR activities. However, there are companies from other…

At Venus Remedies, corporate social responsibility is not a modular add-on to the business; it is core to the business itself. The…

AstraZeneca India, established in 1979 and head-quartered at Bengaluru, Karnataka believes in improving health which is one of the…

No other industry touches a billion lives as much as pharmaceuticals, with a potential to improve health outcomes of people…

Ashland Speciality Ingredients, a commercial unit of Ashland is increasing the price of its portfolio of hydroxyethylcellulose…

Self-owned brands to get a major boost especially in the fields of anti-infectives, lifestyle diseases, dermatology and neurology…

Adarsh Kataruka, Director, SoulAce Social Venture, talks about why each company needs to chart a CSR vision and work towards…

I had ended my last edit with the hope that this year, unlike previous years, the pharmaceutical sector’s hopes would not be as…

With a 5.7 per cent growth in sales in 2013, Boehringer Ingelheim (BI) ranks seventh among its global peers but has a long way to…

The investment will fund the launch of a range of drugs in the areas of respiratory, oncology and antiretroviral medicines

Creates an innovative new model in speciality pharma leadership

The programme combines grants portfolio with annual €20 million investment to advance innovation and medical education

Donates 500 tubes of REGEN-D to AP CM’s Relief Fund